Ambu A/S (OTCMKTS:AMBBY) Releases Earnings Results

Ambu A/S (OTCMKTS:AMBBY) announced its earnings results on Friday. The company reported $0.07 earnings per share (EPS) for the quarter, reports. Ambu A/S had a net margin of 7.23% and a return on equity of 6.80%. The company had revenue of $199.56 million for the quarter.

Ambu A/S Trading Down 18.7 %

Shares of OTCMKTS AMBBY opened at $18.42 on Monday. The company’s 50 day simple moving average is $20.10 and its 200 day simple moving average is $18.33. Ambu A/S has a fifty-two week low of $9.45 and a fifty-two week high of $22.65. The firm has a market capitalization of $4.33 billion and a P/E ratio of 92.10. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.53 and a quick ratio of 1.49.

Ambu A/S Company Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.